Executive Summary
The November 13, 2026 filing batch is dominated by distress and regulatory friction: 6 of 11 filings involve companies in or emerging from insolvency (Arshiya, SKIL, Astron, GVK, Kohinoor, Transgene), with three unable to file Q2 FY27 results on time.
A clear pattern of non-compliance is emerging—Arshiya, SKIL, and Astron all cite CIRP-related disruptions, record unavailability, or management non-cooperation, while Transgene and Kohinoor face NCLT/SEBI proceedings. In contrast, Royal Orchid Hotels delivered strong YoY growth (revenue +56.9%, PAT +243%) but carries a qualified review and regulatory overhang, and Rane Holdings received a favorable GST order dropping a Rs.11.88 crore demand. The batch also includes a SEBI warning to Austere Systems for disclosure lapses and a SEBI recovery attachment release for an unnamed party. Key period trends: hospitality is the sole bright spot with robust YoY growth, while CIRP companies show revenue contraction (GVK -11.5% YoY) and widening losses (GVK consolidated loss up 20% YoY). The most critical development is GVK's CIRP restoration with a 120-day deadline and asset-wise sale re-initiation, signaling prolonged uncertainty. Portfolio-level, the filings underscore elevated regulatory scrutiny (SEBI actions on Kohinoor, Austere, Royal Orchid) and the severe operational impact of insolvency on reporting and governance.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance · Insolvency
Tracking the trend? Catch up on the prior India BSE NSE Trading Suspension Orders digest from November 05, 2026.
Investment Signals (10)
- Royal Orchid Hotels ↓ (MIXED)▲
Consolidated revenue surged 56.9% YoY to ₹11,012.27 lakh and PAT jumped 243% to ₹1,473.42 lakh, but standalone revenue declined 9.7% QoQ and auditors issued a qualified review
- Transgene Biotek ↓ (BEARISH)▲
Q2 revenue rose 13.6% YoY to ₹6.00 lakh and net loss narrowed to ₹34.53 lakh from ₹38.84 lakh, yet finance costs of ₹28.95 lakh dwarf revenue and negative equity stands at ₹-8,570.41 lakh
- Rane Holdings ↓ (BULLISH)▲
GST proceedings for FY23 dropped entirely, eliminating a Rs.11.88 crore demand (including Rs.1.07 crore penalty); financial impact nil but removes overhang
- GVK Power & Infrastructure ↓ (BEARISH)▲
Auditor issued Disclaimer of Conclusion; consolidated loss widened to ₹145 lakh from ₹121 lakh YoY despite 6.8% revenue decline; CIRP restored with 120-day deadline
- Kohinoor Foods ↓ (BEARISH)▲
Auditors qualified over unrecognized interest of ₹176.65 lakh (H1) on invoked guarantee; net worth negative; SEBI Show Cause Notice issued; rights issue of ₹105 crore initiated
- Arshiya Limited ↓ (BEARISH)▲
Unable to file Q2 FY27 results due to CIRP; 50 of 71 employees resigned without notice; subsidiary financials unavailable
- SKIL Infrastructure ↓ (BEARISH)▲
Q2 FY27 results not filed; CIRP ongoing since Feb 2024; auditors refused to sign until pre-CIRP dues cleared; Section 19 non-cooperation application filed
- Astron Paper & Board Mill ↓ (BEARISH)▲
Q2 FY27 results and share capital audit report not filed; RP cites non-cooperation by erstwhile management; BSE due date Nov 14, 2026
- Austere Systems ↓ (NEUTRAL)▲
SEBI Warning-cum-Advisory Letter dated Oct 1, 2026 for disclosure lapse regarding NCLAT order; board reviewing corrective measures
- SEBI Recovery Release (NEUTRAL)▲
Attachment on bank accounts, lockers, demat accounts, and MF folios released under Recovery Certificate No. 7251 of 2023; indicates resolution
Risk Flags (8)
- GVK Power & Infrastructure↓ [HIGH RISK]▼
Auditor disclaimer, admitted CIRP claims of ₹15,94,489 lakh, and NCLT-ordered 120-day CIRP completion by mid-February 2027 create high uncertainty; resolution plans rejected
- Kohinoor Foods↓ [HIGH RISK]▼
Negative net worth, qualified audit, SEBI Show Cause Notice, and unrecognized interest liability of ₹1,704.94 lakh cumulative; going-concern doubt
- Arshiya Limited↓ [HIGH RISK]▼
CIRP since April 2024, mass employee exodus (50/71), and inability to file results; board suspended
- SKIL Infrastructure↓ [HIGH RISK]▼
CIRP since Feb 2024, auditors refusing to sign, Company Secretary non-cooperation, and results only finalized to Dec 2025; reporting lag exceeds 2 years
- Astron Paper & Board Mill↓ [HIGH RISK]▼
CIRP since May 2026, records unavailable, and non-compliance with SEBI LODR; BSE deadline Nov 14, 2026 likely missed
- Transgene Biotek↓ [HIGH RISK]▼
Negative equity of ₹-8,570.41 lakh, finance costs 4.8x revenue, and multiple legal proceedings including NCLT penalty notice under Section 65
- Royal Orchid Hotels↓ [MEDIUM RISK]▼
Qualified limited-review report, SEBI penalties (₹5 lakh + ₹1 lakh) under appeal, and NCLT oppression petition hearing on Nov 26, 2026
- Austere Systems↓ [MEDIUM RISK]▼
SEBI warning for disclosure lapse signals weak compliance controls; potential for further regulatory action
Opportunities (6)
- Royal Orchid Hotels↓ (OPPORTUNITY)◆
Strong YoY growth (revenue +56.9%, PAT +243%) and SAT appeal order reserved; favorable ruling could remove overhang and re-rate stock
- Rane Holdings↓ (OPPORTUNITY)◆
GST demand dropped, removing a Rs.11.88 crore contingent liability; positive for sentiment and cash flow
- Kohinoor Foods↓ (SPECULATIVE)◆
Rights issue of up to ₹105 crore and full OTS discharge could improve capital structure; settlement proceedings with SEBI may resolve regulatory issues
- GVK Power & Infrastructure↓ (SPECULATIVE)◆
Asset-wise sale re-initiation may attract new bidders; 120-day deadline could accelerate resolution
- Transgene Biotek↓ (SPECULATIVE)◆
Loss narrowed YoY and other expenses fell 57%; if finance costs are restructured, path to profitability improves
- SEBI Recovery Release (NEUTRAL)◆
Release of attachments may free up assets for the affected party, potentially improving liquidity
Sector Themes (5)
- Insolvency Overhang◆
6 of 11 filings involve CIRP or NCLT proceedings; all show revenue contraction or inability to report, with GVK, Arshiya, SKIL, and Astron unable to file Q2 FY27 results on time
- Regulatory Scrutiny◆
SEBI actions against Kohinoor (Show Cause), Austere (Warning), Royal Orchid (penalties), and a recovery release; 4 of 11 filings involve SEBI enforcement or advisory
- Audit Qualifications◆
3 companies (Royal Orchid, Kohinoor, GVK) received qualified or disclaimer opinions, citing going-concern doubts, unrecognized liabilities, or scope limitations
- Hospitality Outperformance◆
Royal Orchid stands out with 56.9% YoY revenue growth and 243% PAT growth, contrasting with distress in infrastructure and manufacturing
- Management Non-Cooperation◆
Arshiya, SKIL, and Astron all cite non-cooperation from former management or auditors, highlighting governance breakdown in CIRP cases
Watch List (7)
-
NCLT-mandated 120-day CIRP completion by mid-February 2027; watch for new resolution plans and CoC decisions
-
SAT order reserved after Oct 15, 2026 hearing; NCLT oppression petition hearing on Nov 26, 2026; any adverse ruling could impact stock
-
SEBI settlement proceedings and rights issue progress; watch for resolution of qualified audit issue
-
BSE due date for Q2 FY27 results was Nov 14, 2026; likely non-compliance and potential further regulatory action
-
Section 19 non-cooperation application IA No. 4015 of 2025 pending; watch for NCLT direction on auditors
-
NCLT Hyderabad hearing on BIRAC petition and Section 65 penalty notice; ED Appellate Tribunal matter adjourned to Jan 12, 2027
-
Implementation of corrective measures following SEBI warning; any further disclosure lapses could escalate
Filing Analyses
(11)
13-11-2026
Arshiya Limited disclosed that it cannot submit its Un-Audited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026, citing its ongoing Corporate Insolvency Resolution Process (CIRP) under the IBC initiated by NCLT Mumbai order dated April 23, 2024, with Mr. Pankaj Mahajan as Resolution Professional. The company also cited disruption from relocating its registered office effective April 29, 2024 and the resignation of 50 out of 71 employees between July 30 and August 2, 2024 without notice or handover, plus non-receipt of financials from multiple subsidiaries hampering consolidation. No financial figures were provided in this filing.
- · NCLT Mumbai order No. IA 4395/2024 IA 4382/2024 IN C.P. (IB)/3143(MB)2019 dated April 23, 2024 initiated CIRP; powers of the Board of Directors remain suspended and are exercised exclusively by the Resolution Professional
- · Registered office relocated from Ceejay House, Worli, Mumbai – 400 018 to Arshiya FTWZ, Sai Village, Panvel, Raigad – 410 221 effective April 29, 2024
- · Delay attributed to Resolution Professional's ongoing data collection and non-receipt of financials from multiple subsidiaries affecting consolidated statements
- · Disclosure made pursuant to SEBI Regulation 33 read with SEBI Master Circular dated January 30, 2026
- · Scrip Symbol ARSHIYA, BSE Scrip Code 506074, ISIN INE968D01022, CIN L93000MH1981PLC024747
- · Resolution Professional's IBBI AFA registration valid up to 31-12-2026
13-11-2026
Transgene Biotek reported Q2 FY27 revenue from operations of ₹6.00 Lakh, up 13.6% YoY from ₹5.28 Lakh, while the half-year top line rose 17.3% to ₹12.00 Lakh. However, the company remains deeply loss-making with a Q2 net loss of ₹34.53 Lakh (narrowed from ₹38.84 Lakh YoY) and a half-year loss of ₹73.43 Lakh, driven by finance costs of ₹28.95 Lakh in the quarter that dwarf revenue. The filing also discloses multiple ongoing legal/regulatory proceedings, including a BIRAC petition at NCLT Hyderabad, an ED Appellate Tribunal matter, a ₹92,99,250 recovery order in the Nitin Didwania case under appeal, and a fresh NCLT notice on possible penalty under Section 65, partially offset by dismissal of the Babaji Netralayya petition.
- · Other expenses fell to ₹4.07 Lakh in Q2 FY27 from ₹9.40 Lakh YoY, and to ₹12.52 Lakh in H1 from ₹23.47 Lakh
- · Employee benefits expense was ₹3.38 Lakh in Q2 FY27 vs ₹3.31 Lakh YoY; H1 fell to ₹6.75 Lakh from ₹8.03 Lakh
- · Depreciation and amortisation was ₹4.13 Lakh in Q2 FY27 vs ₹4.98 Lakh YoY
- · Total expenses declined to ₹40.53 Lakh in Q2 FY27 from ₹44.12 Lakh YoY
- · Standalone other equity stood at -₹8570.41 Lakh as at 30 September 2026, with negative net worth of -₹993.41 Lakh
- · Standalone total assets were ₹3371.31 Lakh; non-current loans ₹2302.04 Lakh and provisions ₹2302.04 Lakh
- · Consolidated other equity was -₹6812.73 Lakh with positive net worth of ₹764.27 Lakh; consolidated non-current provisions ₹11522.14 Lakh
- · Net cash flow from operating activities was -₹7.13 Lakh for H1 FY27; financing activities generated ₹7.45 Lakh via ₹65.35 Lakh borrowings
- · Cash and cash equivalents at end of period ₹6.40 Lakh
- · SAT matter heard on 23 September, 16 October and 29 October 2026 but not yet final; ED Appellate Tribunal matter adjourned to 12 January 2027
- · BIRAC filed petition at NCLT Hyderabad claiming outstanding interest; notice served 5 November 2026
- · NCLT dismissed Babaji Netralayya petition on 5 November 2026, but a notice dated 6 November 2026 flags possible penalty under Section 65
- · Zero investor complaints pending or received during the quarter
- · Statutory auditors completed Limited Review; results approved by Board on 13 November 2026
13-11-2026
Transgene Biotek reported Q2 FY27 revenue from operations of ₹6.00 Lakh, up 13.6% YoY from ₹5.28 Lakh, while the net loss narrowed to ₹34.53 Lakh from ₹38.84 Lakh YoY. However, finance costs rose 9.5% YoY to ₹28.95 Lakh and remain the dominant expense, dwarfing revenue, and the company continues to carry negative other equity of ₹-8570.41 Lakh (standalone). The filing also discloses multiple ongoing legal/regulatory proceedings, including a BIRAC petition at NCLT Hyderabad, an ED Appellate Tribunal matter adjourned to 12 January 2027, and a fresh NCLT notice on possible penalty under Section 65, partially offset by dismissal of the Babaji Netralayya petition on 5 November 2026.
- · Other expenses fell sharply to ₹4.07 Lakh in Q2 FY27 from ₹9.40 Lakh YoY, aiding the narrower loss
- · Employee benefits expense rose to ₹3.38 Lakh from ₹3.31 Lakh YoY
- · Standalone other equity stood at ₹-8570.41 Lakh as at 30 September 2026, versus ₹-8496.98 Lakh at 31 March 2026
- · Standalone total assets were ₹3371.31 Lakh; non-current loans ₹2302.04 Lakh and provisions ₹2302.04 Lakh
- · Cash and cash equivalents at end of period ₹6.40 Lakh; net cash flow from operating activities ₹-7.13 Lakh
- · Proceeds from borrowings of ₹65.35 Lakh in H1 FY27; finance costs paid ₹57.90 Lakh
- · SAT matter heard 23 September, 16 October and 29 October 2026 without finality
- · ED Appellate Tribunal matter adjourned to 12 January 2027
- · BIRAC filed petition at NCLT Hyderabad claiming outstanding interest; notice served 5 November 2026
- · NCLT dismissed Babaji Netralayya petition on 5 November 2026, but a notice served 6 November 2026 flags possible Section 65 penalty
- · Consolidated trade receivables shown as 84,214.00 (Lakh) versus 0.84 at 31 March 2026
13-11-2026
Royal Orchid Hotels reported consolidated revenue from operations of ₹11012.27 lakh for Q2 FY27 versus ₹7018.78 lakh in Q2 FY26 (up ~56.9% YoY), with consolidated PAT rising to ₹1473.42 lakh from ₹429.21 lakh. However, on a sequential basis consolidated revenue was roughly flat (₹11012.27 lakh vs ₹10721.38 lakh in Q2 FY26) and standalone revenue of ₹5728.43 lakh was up ~23.6% YoY but down ~9.7% QoQ from ₹6333.00 lakh. The results carry a qualified limited-review report and ongoing regulatory/litigation overhang: a SEBI final order (11 Oct 2024) on KSDPL classification, currently under appeal before SAT (order reserved after 15 Oct 2026 hearing), and an NCLT oppression/mismanagement petition (next hearing 26 Nov 2026).
- · Statutory auditors issued a qualified limited-review report on both standalone and consolidated results.
- · SEBI final order (11 Oct 2024) directed monetary penalties of ₹5 lakh and ₹1 lakh under Sections 15HA and 15HB; 50% deposited, order stayed by SAT.
- · SAT last heard the SEBI appeal on 15 October 2026 and has reserved its order.
- · NCLT oppression/mismanagement petition by Tambi Group (50% KSDPL shareholders) pending; next hearing 26 November 2026.
- · Sale of Multi Hotels Limited (Tanzania) completed 6 July 2026 for USD 3.41 million; net gain of ₹793.23 lakh booked as exceptional item.
- · Final dividend of 25% (₹2.5 per equity share) approved at AGM on 26 September 2026, cash outflow ₹685.63 lakh.
- · Additional gratuity liability of ₹56.04 lakh recognised due to new Labour Codes effective 21 November 2025.
- · Consolidated H1 FY27 revenue ₹21733.65 lakh vs ₹15705.26 lakh in H1 FY26.
- · Unaudited subsidiaries contributed total assets of ₹14,944.11 lakh, revenues of ₹1,112.55 lakh (quarter) and ₹2,248.25 lakh (H1), and net profit of ₹11.90 lakh (quarter) and ₹298.52 lakh (H1).
13-11-2026
Austere Systems Limited's Board approved the Unaudited Standalone and Consolidated Financial Results for the half-year ended 30th September 2026, along with Limited Review Reports, and submitted the Regulation 32 statement of deviation/variation for public issue proceeds. Separately, the Board took note of a SEBI Warning-cum-Advisory Letter dated October 1, 2026 concerning the company's disclosure of an NCLAT order dated September 23, 2025, and reviewed corrective measures to strengthen compliance processes. No actual financial figures were included in the filing content, so quantitative results could not be extracted.
- · Board meeting held Friday, November 13, 2026, commenced at 03:00 P.M. and concluded at 03:45 P.M.
- · Financial results approved are for the half-year ended 30th September, 2026 (unaudited, standalone and consolidated)
- · SEBI Warning-cum-Advisory Letter dated October 1, 2026 relates to disclosure of an NCLAT order dated September 23, 2025
- · Regulation 32 statement of deviation/variation submitted for public issue proceeds for the half-year ended September 30, 2026
- · Scrip Code: 544505 (BSE SME Platform); CIN: L74900PN2015PLC155381
- · Registered office: Nigdi, Pune, Maharashtra-411044; Corporate office: Vipul Plaza, Golf Course Road, Gurugram, Haryana-122002
12-11-2026
SEBI issued an order dated November 12, 2026 releasing attachments on bank accounts, lockers, demat accounts, and mutual fund folios in connection with Recovery Certificate No. 7251 of 2023. The order is a recovery-proceedings action that lifts restrictions previously placed on the affected assets, indicating a resolution or partial closure of the recovery matter. No monetary amounts, penalties, or named parties are disclosed in the filing.
- · Recovery Certificate No. 7251 of 2023 is the underlying enforcement matter referenced in the order
- · The release covers bank accounts, lockers, demat accounts, and mutual fund folios
- · Order published under SEBI's Enforcement / Recovery Proceedings section
13-11-2026
Kohinoor Foods Limited approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, with the auditors issuing a qualified conclusion over unrecognised interest of ₹90.04 lakh (quarter) and ₹176.65 lakh (half year) on an invoked corporate guarantee, cumulative ₹1,704.94 lakh. The company reported a material going-concern uncertainty as net worth remains negative, though it has fully discharged its One Time Settlement with lenders and initiated a rights issue of up to ₹105 crore. A SEBI Show Cause Notice has been issued to the company and its directors, with settlement proceedings underway, while a vendor settlement resulted in an exceptional interest cost of ₹1145.40 lakh and a ₹387 lakh write-off.
- · Auditors issued a qualified conclusion over non-recognition of interest on invoked corporate guarantee; finance costs understated by ₹90.04 lakh (quarter) and ₹176.65 lakh (half year), financial liabilities understated by ₹1,704.94 lakh
- · Material uncertainty on going concern as net worth continues to be negative as at September 30, 2026
- · SEBI Show Cause Notice issued to company and directors under Rule 4 of SEBI (Procedure for Holding Inquiry and Imposing Penalties) Rules, 1995; settlement application filed and hearing granted
- · Company fully discharged OTS amount with interest; NOCs obtained from all 6 lenders, consolidated NOC from Lead Bank pending
- · DRT order dated 28.10.2025 against company; Lead Bank withdrew case and issued NOC after full OTS payment; DRAT appeal withdrawn
- · Pinnacle Tower, Surajkund premises vacation notice matter pending; next hearing December 7, 2026
- · No deferred tax expense/income accounted during the quarter; to be reviewed at year end
- · Company operates as a single segment (manufacturing, trading & marketing of food products) per Ind AS 108
13-11-2026
SKIL Infrastructure Ltd disclosed that it has not submitted its financial results for the quarter and half year ended September 30, 2026 under Regulation 33 of SEBI (LODR) Regulations, 2015, because it remains under Corporate Insolvency Resolution Process admitted by NCLT Mumbai on February 1, 2024. The NCLAT vacated its February 12, 2024 stay on October 15, 2025, allowing the Committee of Creditors to be constituted; in its first meeting on November 3, 2025 the CoC approved Purusottam Behera (IRP) as Resolution Professional. The company has only recently finalized results up to December 31, 2025, citing prolonged litigation plus non-cooperation from its Company Secretary and statutory auditors (the latter refusing until pre-CIRP dues were cleared, prompting a Section 19 non-cooperation application IA No. 4015 of 2025 filed August 23, 2025), and is compiling subsequent periods in phases.
- · NCLT Mumbai admitted a Section 7 IBC application against the company by order dated February 1, 2024, commencing CIRP
- · NCLAT interim order dated February 12, 2024 stayed constitution of the Committee of Creditors in Company Appeal (AT) (Ins.) No. 244 of 2024 (Bhavesh Gandhi vs. Amluckie Investment Company Ltd.)
- · NCLAT Principal Bench order dated October 15, 2025 vacated the stay and permitted withdrawal of the appeal
- · First CoC meeting held Monday, November 3, 2025 approved appointment of Purusottam Behera as Resolution Professional
- · Section 19(2) IBC application IA No. 1557 of 2024 filed against the Company Secretary for non-cooperation
- · Section 19 IBC non-cooperation application IA No. 4015 of 2025 filed against statutory auditors before NCLT on August 23, 2025
- · Statutory auditors expressed willingness to cooperate via email dated October 31, 2025
- · Financial results finalized and submitted only up to the quarter ended December 31, 2025; results for subsequent periods still pending
- · Purusottam Behera IBBI Registration No. IBBI/IPA-002/IP-N00940/2019-20/12993, AFA valid till December 31, 2026
- · NSE Symbol: SKIL; BSE Scrip Code: 539861; CIN L36911MH1983PLC178299
13-11-2026
Astron Paper & Board Mill Limited, currently under Corporate Insolvency Resolution Process (CIRP) commenced via NCLT Ahmedabad order dated May 11, 2026, has responded to NSE/BSE deficiency notices regarding non-submission of financial results and share capital audit reports for the quarter ended September 30, 2026. The Resolution Professional (CA Atul J Sheth) attributes the non-compliance to non-availability of records, difficulties in reconciling historical information, and non-cooperation by the suspended erstwhile management. The company has also failed to submit its Annual Report for FY ended March 31, 2026 under Regulation 34 of SEBI LODR, citing unresolved technical issues on the MCA portal, and has requested the exchanges grant reasonable time while disclaiming RP liability for pre-CIRP non-compliances.
- · CIRP commenced pursuant to NCLT Ahmedabad Bench order dated May 11, 2026
- · Financial Results for quarter ended June 30, 2026 could not be finalized within prescribed timeline
- · BSE set November 14, 2026 as due date for submission of quarterly results for quarter ended September 30, 2026
- · Annual Report for FY ended March 31, 2026 not submitted under Regulation 34 of SEBI (LODR) Regulations, 2015
- · Form GNL-1 could not be filed on MCA portal due to unresolved technical issues; complaint ticket raised with MCA helpdesk
- · Disclosure under Regulation 23(9) on related party transactions pending, to be submitted simultaneously with financial results
- · Company contends Escrow Payment Mechanism disclosure (SEBI circular Nov 2019 on Municipal Bond Debt Securities) is not applicable to it
- · RP's IBBI authorization valid till June 30, 2027
- · BSE Scrip Code: 540824; NSE Symbol: ASTRON; CIN: L21090GJ2010P1C063428
13-11-2026
Rane Holdings Limited disclosed that its wholly owned subsidiary Rane Steering Systems Private Limited (RSSL) received an order dated November 12, 2026 from the Assistant Commissioner (ST), Royapettah South-I, Chennai, dropping GST proceedings in entirety for Financial Year 2022-23. The original demand concerned differences between GSTR-2A and GSTR-3B relating to credit notes and exempted/nil-rated supplies amounting to Rs.11.88 Crore including a penalty of Rs.1.07 Crore. The financial implication on the listed company is Nil, a favorable outcome for the company.
- · Order was issued under Section 73 of the TNGST Act, 2017
- · Date of receipt of communication: November 12, 2026
- · Communication received from Assistant Commissioner (ST), Royapettah South-I, Chennai
- · Applicable period: Financial Year 2022-23
- · No aberrations/non-compliances identified by the authority
- · No penalty or restriction or sanction imposed pursuant to the communication
- · Explanations furnished by RSSL with supporting documents were examined and accepted by the GST Authority
- · This follows the company's earlier letter no. RHL/SE/039/2026-27 dated July 18, 2026 intimating receipt of Show Cause Notice(s)
- · Disclosure made under Regulation 30(13) of SEBI LODR read with SEBI Master Circular dated January 30, 2026
13-11-2026
GVK Power & Infrastructure Limited, currently under CIRP, reported standalone Q2 FY27 (quarter ended 30.09.2026) total income of ₹77 Lakh versus ₹87 Lakh in Q2 FY26 (down ~11.5% YoY), with a net loss of ₹15 Lakh versus ₹16 Lakh a year earlier. Consolidated Q2 FY27 total income was ₹123 Lakh versus ₹132 Lakh in Q2 FY25 (down ~6.8% YoY), while consolidated loss after tax narrowed to ₹145 Lakh from ₹121 Lakh prior year (loss widened). The statutory auditor (T R Chadha & Co LLP) issued a Disclaimer of Conclusion citing going-concern doubt, unprovided guarantees/claims (admitted CIRP claims of ₹15,94,489 Lakh including ₹14,89,486 Lakh from GVK Coal Developers creditors), and NCLT Hyderabad's October 16, 2026 order restoring CIRP with a 120-day completion deadline.
- · Auditor issued a Disclaimer of Conclusion on both standalone and consolidated results, unable to comment on going-concern assumption.
- · NCLT Hyderabad Bench-II order dated October 16, 2026 restored CIRP and directed completion within 120 days.
- · Two resolution plans received from Prospective Resolution Applicants were rejected by CoC as non-compliant; CoC resolved to re-initiate CIRP on asset-wise sale basis.
- · NCLT Hyderabad rejected the Resolution Plan for GVK Energy Limited despite 100% CoC approval, citing deficiencies.
- · Liquidation proceedings commenced (information received October 29, 2026) for five Australian subsidiaries of GVK Coal Developers.
- · England Court order dated October 19, 2023 crystallized payable amount at USD 2.19 billion including interest; company's legal opinion holds it unenforceable in India.
- · Standalone cash and cash equivalents stood at ₹4,452 Lakh as at September 30, 2026 versus ₹4,432 Lakh at March 31, 2026.
- · Consolidated total equity was negative at ₹(22,196) Lakh as at September 30, 2026.
- · Standalone EPS (basic and diluted) was ₹(0.00) for Q2 FY27 versus ₹(6.58) for FY26 full year.
- · Consolidated EPS (basic and diluted) was ₹(0.01) for Q2 FY27 versus ₹(5.32) for FY26 full year.
- · CBI charge sheet filed February 09, 2023 against MIAL and others; proceedings currently stayed, next listed November 21, 2026 and December 11, 2026.
- · ED PMLA complaint matter listed for arguments on November 25, 2026.
- · GVK Ratle arbitration next hearing scheduled November 20, 2026; award of ₹29,048 Lakh in its favor.
- · Board Meeting commenced at 11:30 a.m. and concluded at 2:30 p.m. on November 13, 2026.
Get daily alerts with 10 investment signals, 8 risk alerts, 6 opportunities and full AI analysis of all 11 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India BSE NSE Trading Suspension Orders
November 04, 2026
India BSE NSE Trading Suspension Orders — November 04, 2026
November 03, 2026
India BSE NSE Trading Suspension Orders — November 03, 2026
November 02, 2026
India BSE NSE Trading Suspension Orders — November 02, 2026
October 31, 2026
India BSE NSE Trading Suspension Orders — October 31, 2026
🇮🇳 More from India
View all →November 06, 2026
India Pre-Market Regulatory Roundup — November 06, 2026
India Pre-Market Regulatory Roundup
November 06, 2026
India Quarterly Results BSE NSE Announcements — November 06, 2026
India Quarterly Results BSE NSE Announcements
November 06, 2026
India Upcoming Corporate Actions BSE NSE — November 06, 2026
India Upcoming Corporate Actions BSE NSE
November 06, 2026
India RBI Monetary Policy Repo Rate Decisions — November 06, 2026
India RBI Monetary Policy Repo Rate Decisions